History
No history yet.
Start a conversation to see it here.
Finance Assistant
Finance Assistant
How can I help you today?
Finance Operations
Analytics and Reporting
Access Requests
Suggested
Create Budget Request in Portfolio
Last 3 months revenue by product
Access to Compensation Mosaic site
Product Masterdata after re-org
Revenue YTD
$42.3B
6.2% vs Plan
Operating Expense
$18.7B
3.1% over budget
Budget Variance
−$5.1M
Primary Care
Pending Approvals
23
5 urgent
Revenue vs Budget
Revenue
Budget
Recent Insights
View all
Revenue up 6.2% vs plan — driven by Oncology and Specialty Care outperformance.
May 15, 2026 · 9:15 AM
Primary Care variance flagged at −$5.4M. Anticoagulant B & Vaccine D show zero sales against available units.
May 11, 2026 · 8:42 AM
Oncology YTD revenue $10.5B — 12% above plan, led by Antiviral Formulations in US market.
May 15, 2026 · 8:25 AM
OpEx running 3.1% over budget YTD. Consulting spend exceeded Q1 allocation by $320K.
May 15, 2026 · 7:30 AM
Lighthouse — Budget Planning
Pre-filtered · Variance correction mode
Active filters
Anticoagulant B Vaccine D FY2026 Zero sales · units available
ProductMarketBudget (Sales)Units avail.Status
Anticoagulant BEurope market$0 ⚠4,200 unitsError
Vaccine DAsia Pacific market$0 ⚠2,850 unitsError
New Message — Outlook
CcAdd a name or email…
SubjectFY2026 Revenue Variance — Budget Planning Error in Lighthouse [Action Required]
Hi Sarah,

I wanted to flag a budget vs. actual variance identified for Q1 2026 in Primary Care:

Anticoagulant B (Europe market): Actual $9.6M vs Budget $12.8M → −$3.2M (−25%)
Vaccine D (Asia Pacific market): Actual $6.5M vs Budget $8.4M → −$1.9M (−23%)

One potential cause: both products had zero sales entered in Lighthouse despite units being available, resulting in an under-budgeted baseline of −$5.1M.

I have opened a correction request in Lighthouse. Please review and approve the reforecast at your earliest convenience.

Happy to walk through the details — let me know.

Best regards
Downloading...
Product_Masterdata_LE.csv